Concord Medical Services
4 hedge funds and large institutions have $247K invested in Concord Medical Services in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
1% less capital invested
Capital invested by funds: $249K → $247K (-$2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$370 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$22K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$907 |
CCM Hedge Fund Activity: Q2 2022 in Review
4 of the 5,958 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2022, worth a combined $247K — down 0.8% from $249K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CCM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $370. The largest seller was Renaissance Technologies, cutting an estimated $22K.
- 4 institutional investors held Concord Medical Services (CCM) as of Q2 2022, up from 3 in Q1 2022.
- Funds reported $247K of Concord Medical Services stock for Q2 2022, down 0.8% quarter-over-quarter.
- 1 fund opened new Concord Medical Services positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Concord Medical Services buyer in Q2 2022 was Citigroup, an estimated $370 added.
- The largest Concord Medical Services seller in Q2 2022 was Renaissance Technologies, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2022.